Ramón Corbalán
About
In The Last Decade
Ramón Corbalán
23 papers receiving 3.3k citations
Hit Papers
Peers
Comparison fields: 5 of 105
- Cardiology and Cardiovascular Medicine 3.0k
- Surgery 1.1k
- Radiology, Nuclear Medicine and Imaging 1.1k
- Internal Medicine 408
- Endocrinology, Diabetes and Metabolism 248
Countries citing papers authored by Ramón Corbalán
This map shows the geographic impact of Ramón Corbalán's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ramón Corbalán with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ramón Corbalán more than expected).
Fields of papers citing papers by Ramón Corbalán
This network shows the impact of papers produced by Ramón Corbalán. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ramón Corbalán. The network helps show where Ramón Corbalán may publish in the future.
Co-authorship network of co-authors of Ramón Corbalán
This figure shows the co-authorship network connecting the top 25 collaborators of Ramón Corbalán. A scholar is included among the top collaborators of Ramón Corbalán based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ramón Corbalán. Ramón Corbalán is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 2 | |
| 3 | Ticagrelor for Prevention of Ischemic Events After Myocardial Infarction in Patients With Peripheral Artery Disease breakdown → | 249 |
| 4 | 7 | |
| 5 | 18 | |
| 6 | Abstract 14508: Vorapaxar for Secondary Prevention after Myocardial Infarction According to Aspirin Dose - Insights from the TRA2{degrees}P-TIMI 50 Trial | 5 |
| 7 | Inflamación y estrés oxidativo en el síndrome coronario agudo: ¿Dos fenómenos relacionados? | 1 |
| 8 | Greater Clinical Benefit of More Intensive Oral Antiplatelet Therapy With Prasugrel in Patients With Diabetes Mellitus in the Trial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet Inhibition With Prasugrel–Thrombolysis in Myocardial Infarction 38 breakdown → | 498 |
| 9 | 16 | |
| 10 | 31 | |
| 11 | 34 | |
| 12 | 2 | |
| 13 | 55 | |
| 14 | The TIMI Risk Score for Unstable Angina/Non–ST Elevation MI breakdown → | 2250 |
| 15 | [Acute myocardial infarction in Chilean hospitals. Final results of the GEMI study]. | 2 |
| 16 | 30 | |
| 17 | [Noncardiogenic pulmonary edema associated with hydrochlorothiazide use]. | 1 |
| 18 | 14 | |
| 19 | 1 | |
| 20 | [Selective coronary arteriography]. | 0 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.